Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: J Periodontol. 2014 Sep 30;86(2):264–272. doi: 10.1902/jop.2014.140354

Figure 2.

Figure 2

Representation of ranked differences in levels of IL-17A between implant and tooth sites for 73 participants, indicating that IL-17A levels at the implant site tended to be greater than those at the tooth site. Higher PISF levels of IL-17A relative to GCF (red bars) were found in 61.6% of participants (sign test, p=0.023).